AR102494A1 - METHODS TO TREAT EYE DISEASES - Google Patents
METHODS TO TREAT EYE DISEASESInfo
- Publication number
- AR102494A1 AR102494A1 ARP150103539A ARP150103539A AR102494A1 AR 102494 A1 AR102494 A1 AR 102494A1 AR P150103539 A ARP150103539 A AR P150103539A AR P150103539 A ARP150103539 A AR P150103539A AR 102494 A1 AR102494 A1 AR 102494A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- eye diseases
- treat eye
- treatment
- burden
- Prior art date
Links
Abstract
Método para reducir la carga del tratamiento para pacientes que padecen un trastorno neovascular intraocular, donde el método comprende administrar una cantidad terapéuticamente efectiva del antagonista del VEGF en una administración de la dosificación que incluye intervalos de tratamiento de 8 y/o 12 semanas.Method for reducing the burden of treatment for patients suffering from an intraocular neovascular disorder, where the method comprises administering a therapeutically effective amount of the VEGF antagonist in a dosage administration that includes treatment intervals of 8 and / or 12 weeks.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462076770P | 2014-11-07 | 2014-11-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR102494A1 true AR102494A1 (en) | 2017-03-01 |
Family
ID=58688557
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP150103539A AR102494A1 (en) | 2014-11-07 | 2015-11-02 | METHODS TO TREAT EYE DISEASES |
ARP150103621A AR102572A1 (en) | 2014-11-07 | 2015-11-06 | FORMULATION OF STABLE PROTEIN SOLUTION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP150103621A AR102572A1 (en) | 2014-11-07 | 2015-11-06 | FORMULATION OF STABLE PROTEIN SOLUTION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY |
Country Status (1)
Country | Link |
---|---|
AR (2) | AR102494A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109475597A (en) * | 2017-04-26 | 2019-03-15 | 参天堂制药(株) | Medical composite for eye |
-
2015
- 2015-11-02 AR ARP150103539A patent/AR102494A1/en unknown
- 2015-11-06 AR ARP150103621A patent/AR102572A1/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109475597A (en) * | 2017-04-26 | 2019-03-15 | 参天堂制药(株) | Medical composite for eye |
Also Published As
Publication number | Publication date |
---|---|
AR102572A1 (en) | 2017-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017001117A1 (en) | Methods to treat eye diseases. | |
MX2023008368A (en) | Methods of treating inflammatory conditions. | |
CY1122143T1 (en) | DRUG COMBINATIONS COMPRISING A B-RAF INHIBITOR, AN EGFR INHIBITOR, AND OPTIONALLY A PI3K-ALPHA INHIBITOR | |
PH12017502142A1 (en) | Tetrasubstituted aklene compounds and their use | |
BR112016000546A2 (en) | methods to treat or prevent eye conditions | |
EA201691872A1 (en) | HETEROCYCLIC COMPOUNDS FOR APPLICATION IN THE TREATMENT OF PI3K-GAMMA-MEDIATED DISORDERS | |
BR112017002637A2 (en) | methods to treat or prevent eye conditions | |
MX2021000538A (en) | Sobetirome in the treatment of myelination diseases. | |
EA201691454A1 (en) | COMPOSITIONS OF PRIDOPIDININE MODIFIED SHIPPING | |
BR112017018964A2 (en) | use of plinabulin and methods to treat brain tumor | |
EA201791199A1 (en) | METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | |
EA201890891A1 (en) | BIOMARKERS ASSOCIATED WITH INTERLEYKIN-33 DISEASES, AND THEIR APPLICATION | |
PH12017500933A1 (en) | Sublingual administration of riluzole | |
PH12015501531B1 (en) | Crenolanib for treating flt3 mutated proliferative disorders | |
CR20150637A (en) | TREATMENT OF MIOPATIC AND NEURODEGENERATIVE DISEASES BY PROTEIN AGGREGATION THROUGH PARENTERAL ADMINISTRATION | |
MX2017006938A (en) | Combination therapy for treatment of cancer. | |
PH12017500934A1 (en) | Sublingual formulation of riluzole | |
EA201892265A1 (en) | METHODS OF TREATMENT OF OPHTHALMIC DISEASES | |
MX2019009586A (en) | Compositions and methods for treating disease associated with permeability of intestinal epithelium. | |
CL2019000625A1 (en) | Fxr agonist combination. | |
EA201991175A1 (en) | THE USE OF INTERFERON-LAMBDA IN MEDICINE FOR THE TREATMENT OF FIBROSIS | |
MD20170025A2 (en) | Medical treatments based on anamorelin | |
EA201691656A2 (en) | THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS | |
AR102494A1 (en) | METHODS TO TREAT EYE DISEASES | |
MX2022002947A (en) | Avocatin b for the treatment of diseases and conditions. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |